The global Pharmacokinetics Services market size was valued at USD 640.2 million in 2023 and is forecast to a readjusted size of USD 871.1 million by 2030 with a CAGR of 4.5% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the Pharmacokinetics Services industry chain, the market status of Small & Medium Enterprise (Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services), Large Enterprise (Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmacokinetics Services.
Regionally, the report analyzes the Pharmacokinetics Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmacokinetics Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmacokinetics Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmacokinetics Services industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmacokinetics Services market.
Regional Analysis: The report involves examining the Pharmacokinetics Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmacokinetics Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmacokinetics Services:
Company Analysis: Report covers individual Pharmacokinetics Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmacokinetics Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Small & Medium Enterprise, Large Enterprise).
Technology Analysis: Report covers specific technologies relevant to Pharmacokinetics Services. It assesses the current state, advancements, and potential future developments in Pharmacokinetics Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmacokinetics Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Pharmacokinetics Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
麻豆原创 segment by Application
Small & Medium Enterprise
Large Enterprise
麻豆原创 segment by players, this report covers
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmacokinetics Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmacokinetics Services, with revenue, gross margin and global market share of Pharmacokinetics Services from 2019 to 2024.
Chapter 3, the Pharmacokinetics Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharmacokinetics Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmacokinetics Services.
Chapter 13, to describe Pharmacokinetics Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Pharmacokinetics Services
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Pharmacokinetics Services by Type
1.3.1 Overview: Global Pharmacokinetics Services 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Pharmacokinetics Services Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Small Molecules Pharmacokinetics Services
1.3.4 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.4 Global Pharmacokinetics Services 麻豆原创 by Application
1.4.1 Overview: Global Pharmacokinetics Services 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Small & Medium Enterprise
1.4.3 Large Enterprise
1.5 Global Pharmacokinetics Services 麻豆原创 Size & Forecast
1.6 Global Pharmacokinetics Services 麻豆原创 Size and Forecast by Region
1.6.1 Global Pharmacokinetics Services 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Pharmacokinetics Services 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Pharmacokinetics Services 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Pharmacokinetics Services 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Pharmacokinetics Services 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Pharmacokinetics Services 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Pharmacokinetics Services 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Evotec AG (Germany)
2.1.1 Evotec AG (Germany) Details
2.1.2 Evotec AG (Germany) Major Business
2.1.3 Evotec AG (Germany) Pharmacokinetics Services Product and Solutions
2.1.4 Evotec AG (Germany) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Evotec AG (Germany) Recent Developments and Future Plans
2.2 Pacific BioLabs (US)
2.2.1 Pacific BioLabs (US) Details
2.2.2 Pacific BioLabs (US) Major Business
2.2.3 Pacific BioLabs (US) Pharmacokinetics Services Product and Solutions
2.2.4 Pacific BioLabs (US) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Pacific BioLabs (US) Recent Developments and Future Plans
2.3 GVK Biosciences Private Limited (India)
2.3.1 GVK Biosciences Private Limited (India) Details
2.3.2 GVK Biosciences Private Limited (India) Major Business
2.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product and Solutions
2.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 GVK Biosciences Private Limited (India) Recent Developments and Future Plans
2.4 Shanghai Medicilon Inc. (China)
2.4.1 Shanghai Medicilon Inc. (China) Details
2.4.2 Shanghai Medicilon Inc. (China) Major Business
2.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product and Solutions
2.4.4 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Shanghai Medicilon Inc. (China) Recent Developments and Future Plans
2.5 Pharmaceutical Product Development, LLC (US)
2.5.1 Pharmaceutical Product Development, LLC (US) Details
2.5.2 Pharmaceutical Product Development, LLC (US) Major Business
2.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product and Solutions
2.5.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments and Future Plans
2.6 Charles River Laboratories International, Inc. (US)
2.6.1 Charles River Laboratories International, Inc. (US) Details
2.6.2 Charles River Laboratories International, Inc. (US) Major Business
2.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product and Solutions
2.6.4 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Charles River Laboratories International, Inc. (US) Recent Developments and Future Plans
2.7 PAREXEL International Corporation (US)
2.7.1 PAREXEL International Corporation (US) Details
2.7.2 PAREXEL International Corporation (US) Major Business
2.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Product and Solutions
2.7.4 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 PAREXEL International Corporation (US) Recent Developments and Future Plans
2.8 Eurofins Scientific, Inc. (Luxembourg)
2.8.1 Eurofins Scientific, Inc. (Luxembourg) Details
2.8.2 Eurofins Scientific, Inc. (Luxembourg) Major Business
2.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product and Solutions
2.8.4 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments and Future Plans
2.9 Frontage Labs (US)
2.9.1 Frontage Labs (US) Details
2.9.2 Frontage Labs (US) Major Business
2.9.3 Frontage Labs (US) Pharmacokinetics Services Product and Solutions
2.9.4 Frontage Labs (US) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Frontage Labs (US) Recent Developments and Future Plans
2.10 SGS SA (Switzerland)
2.10.1 SGS SA (Switzerland) Details
2.10.2 SGS SA (Switzerland) Major Business
2.10.3 SGS SA (Switzerland) Pharmacokinetics Services Product and Solutions
2.10.4 SGS SA (Switzerland) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 SGS SA (Switzerland) Recent Developments and Future Plans
2.11 LGC Limited (UK)
2.11.1 LGC Limited (UK) Details
2.11.2 LGC Limited (UK) Major Business
2.11.3 LGC Limited (UK) Pharmacokinetics Services Product and Solutions
2.11.4 LGC Limited (UK) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 LGC Limited (UK) Recent Developments and Future Plans
2.12 Creative Bioarray (US)
2.12.1 Creative Bioarray (US) Details
2.12.2 Creative Bioarray (US) Major Business
2.12.3 Creative Bioarray (US) Pharmacokinetics Services Product and Solutions
2.12.4 Creative Bioarray (US) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Creative Bioarray (US) Recent Developments and Future Plans
2.13 Certara, L.P. (Germany)
2.13.1 Certara, L.P. (Germany) Details
2.13.2 Certara, L.P. (Germany) Major Business
2.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Product and Solutions
2.13.4 Certara, L.P. (Germany) Pharmacokinetics Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Certara, L.P. (Germany) Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Pharmacokinetics Services Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Pharmacokinetics Services by Company Revenue
3.2.2 Top 3 Pharmacokinetics Services Players 麻豆原创 Share in 2023
3.2.3 Top 6 Pharmacokinetics Services Players 麻豆原创 Share in 2023
3.3 Pharmacokinetics Services 麻豆原创: Overall Company Footprint Analysis
3.3.1 Pharmacokinetics Services 麻豆原创: Region Footprint
3.3.2 Pharmacokinetics Services 麻豆原创: Company Product Type Footprint
3.3.3 Pharmacokinetics Services 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Pharmacokinetics Services Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Pharmacokinetics Services 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Pharmacokinetics Services Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Pharmacokinetics Services 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Pharmacokinetics Services Consumption Value by Type (2019-2030)
6.2 North America Pharmacokinetics Services Consumption Value by Application (2019-2030)
6.3 North America Pharmacokinetics Services 麻豆原创 Size by Country
6.3.1 North America Pharmacokinetics Services Consumption Value by Country (2019-2030)
6.3.2 United States Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Pharmacokinetics Services Consumption Value by Type (2019-2030)
7.2 Europe Pharmacokinetics Services Consumption Value by Application (2019-2030)
7.3 Europe Pharmacokinetics Services 麻豆原创 Size by Country
7.3.1 Europe Pharmacokinetics Services Consumption Value by Country (2019-2030)
7.3.2 Germany Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Pharmacokinetics Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Pharmacokinetics Services 麻豆原创 Size by Region
8.3.1 Asia-Pacific Pharmacokinetics Services Consumption Value by Region (2019-2030)
8.3.2 China Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Pharmacokinetics Services Consumption Value by Type (2019-2030)
9.2 South America Pharmacokinetics Services Consumption Value by Application (2019-2030)
9.3 South America Pharmacokinetics Services 麻豆原创 Size by Country
9.3.1 South America Pharmacokinetics Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Pharmacokinetics Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Pharmacokinetics Services 麻豆原创 Size by Country
10.3.1 Middle East & Africa Pharmacokinetics Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Pharmacokinetics Services 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Pharmacokinetics Services 麻豆原创 Drivers
11.2 Pharmacokinetics Services 麻豆原创 Restraints
11.3 Pharmacokinetics Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Pharmacokinetics Services Industry Chain
12.2 Pharmacokinetics Services Upstream Analysis
12.3 Pharmacokinetics Services Midstream Analysis
12.4 Pharmacokinetics Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
听
听
*If Applicable.
